Regeneron - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeRegeneron
Regeneron logo

Regeneron

0 followers

REGN

Performance

About Regeneron

Regeneron is a biopharmaceutical company that harmonizes biology and technology to develop life-changing medicines. Its focus spans biologics and genetic medicines across oncology/hematology, inflammatory diseases, neuroscience, respiratory and other serious conditions, with operations and clinical development rooted in the United States and global collaborations. The company emphasizes research and development, clinical trials, and a commitment to responsible practices and patient access. Headquartered in the U.S., Regeneron positions itself at the intersection of science and medicine to bring therapies to patients worldwide.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Leonard S. Schleifer, MD, PhD

Board co-Chair, President and Chief Executive Officer

George D. Yancopoulos, MD, PhD

Board co-Chair, President and Chief Scientific Officer

Key Facts

HQ Location

Tarrytown, United States

Founded

1988

Employees

over-10K

Status

Public

Website

https://regeneron.com